Aardvark Therapeutics Inc... (AARD)
NASDAQ: AARD
· Real-Time Price · USD
13.30
-0.63 (-4.52%)
At close: Oct 16, 2025, 3:59 PM
13.04
-1.95%
After-hours: Oct 16, 2025, 07:17 PM EDT
-4.52% (1D)
| Bid | 13 |
| Market Cap | 288.59M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -36.64M |
| EPS (ttm) | -1.69 |
| PE Ratio (ttm) | -7.87 |
| Forward PE | -4.38 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 13.96 |
| Volume | 172,227 |
| Avg. Volume (20D) | 152,981 |
| Open | 14.06 |
| Previous Close | 13.93 |
| Day's Range | 13.03 - 14.06 |
| 52-Week Range | 4.88 - 19.58 |
| Beta | 3.69 |
| Ex-Dividend Date | n/a |
About AARD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AARD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AARD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+11.55%
Aardvark Therapeutics shares are trading lower aft...
Unlock content with
Pro Subscription
6 months ago
+10.39%
Aardvark Therapeutics shares are trading higher after RBC Capital and Cantor Fitzgerald reiterated their respective ratings on the stock and maintained their price targets.
